๐๐š๐ญ๐ข๐ž๐ง๐ญ-๐‚๐ž๐ง๐ญ๐ซ๐ข๐œ ๐๐ฎ๐›๐ฅ๐ข๐œ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐€๐๐ฏ๐จ๐œ๐š๐ญ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐˜๐ž๐š๐ซ

I am deeply humbled to be recognized as the โ€œ๐๐š๐ญ๐ข๐ž๐ง๐ญ-๐‚๐ž๐ง๐ญ๐ซ๐ข๐œ ๐๐ฎ๐›๐ฅ๐ข๐œ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐€๐๐ฏ๐จ๐œ๐š๐ญ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐˜๐ž๐š๐ซโ€ for year 2024 at the ๐‘ƒ๐‘Ž๐‘ก๐‘–๐‘’๐‘›๐‘ก ๐น๐‘–๐‘Ÿ๐‘ ๐‘ก ๐‘†๐‘ข๐‘š๐‘š๐‘–๐‘ก ๐‘Ž๐‘›๐‘‘ ๐ด๐‘ค๐‘Ž๐‘Ÿ๐‘‘๐‘  ๐‘๐‘’๐‘Ÿ๐‘’๐‘š๐‘œ๐‘›๐‘ฆ in Mumbai, in the presence of hundreds of leading policymakers, industry leaders, patient advocates, clinicians, scientists, and society dignitaries.

While the true reward lies in seeing the positive impact on patientsโ€™ lives, this honor is especially meaningful as it spans all disease areasโ€”not just cancerโ€”reflecting the importance of championing public health and placing patients at the heart of care.

This award is not just mine; itโ€™s a testament to the collective efforts of countless #PatientAdvocates who work tirelessly and selflessly for this noble causeโ€ฆand indeed this award is for and in memory of my wife Kusum Malik Tomar โ™ฅ๏ธ

At the core of public health is the belief that โ€œ๐ž๐ฏ๐ž๐ซ๐ฒ ๐ฏ๐จ๐ข๐œ๐ž ๐ฆ๐š๐ญ๐ญ๐ž๐ซ๐ฌ.โ€ Personally, I believe that โ€œ๐ž๐ฏ๐ž๐ซ๐ฒ ๐ฅ๐ข๐Ÿ๐ž ๐ฆ๐š๐ญ๐ญ๐ž๐ซ๐ฌ.โ€ These beliefs inspires me to continue advocating for solutions that truly prioritize the needs of patients.

Together, letโ€™s strive to build a healthier, more equitable future.

#PatientAdvocacy #PublicHealth #PatientsFirst #EquitableHealthcare

Changemaker at the Asia Lung Cancer Conference

Recently, I had the honor of representing the voice of lung cancer patients as the first Indian Patient Advocate to lead a workshop on Patient Advocacy for oncologists, researchers, and emerging patient advocates from across Asia at the Asia Lung Cancer Conference (ACLC) in Hong Kong.

The 2024 Asia Conference on Lung Cancer (ACLC 2024) took place from October 17 to 19, 2024, organized by the International Association for the Study of Lung Cancer (IASLC). This gathering spotlighted the latest advancements in lung cancer research, treatment methodologies, and clinical practices, serving as a beacon of hope for progress in the field.

This platform provided an invaluable opportunity to become a changemaker to foster a transformative shift in patient advocacy for lung cancer across the Asia-Pacific region. It allowed me to bring together patient advocates from various countries, guiding and empowering them with the knowledge, experience, and tools they need to become more effective voices for change.

It was truly inspiring to connect and collaborate with such an incredible group of fellow patient advocacy leaders and dear friends in this groundbreaking initiative, all united by the goal of improving healthcare for cancer patients in Asia.

Special thanks to IASLC team, Janet Freeman (ROS1Ders), Lillian Leigh (Chair of the workshop), and the remarkable Dr. Upal Basu Roy (LUNGevity) for their unwavering support and for making this opportunity possible.